Shandong Xinhua Pharmaceutical Company Limited – FDA 483, Mar 25, 2019
Shandong Xinhua Pharmaceutical Company Limited, an API manufacturer in Zibo, China, was inspected and found to have significant deficiencies across its quality system. The firm failed to adequately investigate out-of-specification results, maintain control over critical manufacturing and laboratory records, and properly implement corrective and preventive actions or change controls. Additionally, the quality unit demonstrated deficient oversight of laboratory electronic systems and data integrity practices.
ID · c944c50e-057c-4ae8-b8ce-4de9d48b6efa
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.